These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32231898)

  • 21. Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis.
    Chen H; Zeng WK; Shi GZ; Gao M; Wang MZ; Shen J
    World J Gastroenterol; 2020 Sep; 26(33):4996-5007. PubMed ID: 32952345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing hepatic steatosis by magnetic resonance in potential living liver donors.
    Kuru Öz D; Ellik Z; Gürsoy Çoruh A; Adıgüzel M; Gümüşsoy M; Kiremitci S; Kırımker OE; Gökcan H; Elhan AH; Balcı D; Savaş B; Erden A; İdilman R
    Diagn Interv Radiol; 2024 Nov; 30(6):351-356. PubMed ID: 38737404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area.
    Kim KY; Song JS; Kannengiesser S; Han YM
    Radiol Med; 2015 Dec; 120(12):1083-93. PubMed ID: 25952293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis.
    Jiang Y; Zou J; Fan F; Yang P; Ma L; Gan T; Wang S; Zhang J
    Sci Rep; 2023 Aug; 13(1):12555. PubMed ID: 37532757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference.
    Heba ER; Desai A; Zand KA; Hamilton G; Wolfson T; Schlein AN; Gamst A; Loomba R; Sirlin CB; Middleton MS
    J Magn Reson Imaging; 2016 Feb; 43(2):398-406. PubMed ID: 26201284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis.
    Elfaal M; Supersad A; Ferguson C; Locas S; Manolea F; Wilson MP; Sam M; Tu W; Low G
    World J Radiol; 2023 Oct; 15(10):293-303. PubMed ID: 37969136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
    Park CC; Hamilton G; Desai A; Zand KA; Wolfson T; Hooker JC; Costa E; Heba E; Clark L; Gamst A; Loomba R; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Apr; 42(4):1189-1198. PubMed ID: 28028556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
    World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
    Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.
    Kukuk GM; Hittatiya K; Sprinkart AM; Eggers H; Gieseke J; Block W; Moeller P; Willinek WA; Spengler U; Trebicka J; Fischer HP; Schild HH; Träber F
    Eur Radiol; 2015 Oct; 25(10):2869-79. PubMed ID: 25903702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
    Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R
    Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.
    Ligabue G; Besutti G; Scaglioni R; Stentarelli C; Guaraldi G
    Quant Imaging Med Surg; 2013 Aug; 3(4):192-5. PubMed ID: 24040614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
    Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
    J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.
    Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB
    J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
    Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diurnal Variation of Proton Density Fat Fraction in the Liver Using Quantitative Chemical Shift Encoded MRI.
    Colgan TJ; Van Pay AJ; Sharma SD; Mao L; Reeder SB
    J Magn Reson Imaging; 2020 Feb; 51(2):407-414. PubMed ID: 31168893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-echo Dixon and breath-hold T2-corrected multi-echo single-voxel MRS for quantifying hepatic iron overload in rabbits.
    Zhao F; Chen Y; Zhang H; Li C; Long L
    Acta Radiol; 2023 Jan; 64(1):13-19. PubMed ID: 34904894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.